Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1440, Issue 2-3, 1999, Pages 205-214

  Katayama, Kazuhisa ^a   Ueda, Natsuo ^a   Katoh, Itsuo ^a   Yamamoto, Shozo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Amidohydrolase; Anandamide; Arachidonic acid; Cannabinoid; Equilibrium constant; Palmitoylethanolamide

Indexed keywords

AMIDASE; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; COMPLEMENTARY DNA; ETHANOLAMINE; HYDROLASE INHIBITOR;

ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PURIFICATION; EQUILIBRIUM CONSTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMIDOHYDROLASES; AMINO ACID SEQUENCE; ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CANNABINOIDS; ETHANOLAMINE; KINETICS; MOLECULAR SEQUENCE DATA; POLYUNSATURATED ALKAMIDES; PROTEASE INHIBITORS; RATS; RECOMBINANT PROTEINS; TOSYL COMPOUNDS;

INSECTA; UNIDENTIFIED BACULOVIRUS;

EID: 0032829859     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(99)00124-9     Document Type: Article

References (34)

1. 2 receptors. Pharmacol. Ther. 74:1997;129-180.
2. Di Marzo V. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta. 1392:1998;153-175.
3. Felder C.C. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38:1998;179-200.
4. Devane W.A., Hanuš L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
5. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46:1993;791-796.
6. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
7. Desarnaud F., Cadas H., Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270:1995;6030-6035.
8. Ueda N., Kurahashi Y., Yamamoto S., Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270:1995;23823-23827.
9. Schmid P.C., Zuzarte-Augustin M.L., Schmid H.H.O. Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem. 260:1985;14145-14149.
10. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384:1996;83-87.
11. Kurahashi Y., Ueda N., Suzuki H., Suzuki M., Yamamoto S. Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase. Biochem. Biophys. Res. Commun. 237:1997;512-515.
12. Arreaza G., Devane W.A., Omeir R.L., Sajnani G., Kunz J., Cravatt B.F., Deutsch D.G. The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine. Neurosci. Lett. 234:1997;59-62.
13. Schmid P.C., Schwindenhammer D., Krebsbach R.J., Schmid H.H.O. Alternative pathways of anandamide biosynthesis in rat testes. Chem. Phys. Lipids. 92:1998;27-35.
14. Paria B.C., Deutsch D.G., Dey S.K. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol. Reprod. Dev. 45:1996;183-192.
15. Ueda N., Yamamoto K., Yamamoto S., Tokunaga T., Shirakawa E., Shinkai H., Ogawa M., Sato T., Kudo I., Inoue K., Takizawa H., Nagano T., Hirobe M., Matsuki N., Saito H. Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim. Biophys. Acta. 1254:1995;127-134.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
17. Katayama K., Ueda N., Kurahashi Y., Suzuki H., Yamamoto S., Kato I. Distribution of anandamide amidohydrolase in rat tissues with special reference with small intestine. Biochim. Biophys. Acta. 1347:1997;212-218.
18. Patricelli M.P., Lashuel H.A., Giang D.K., Kelly J.W., Cravatt B.F. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry. 37:1998;15177-15187.
19. Kruszka K.K., Gross R.W. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. J. Biol. Chem. 269:1994;14345-14348.
20. Devane W.A., Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. USA. 91:1994;6698-6701.
21. Hillard C.J., Wilkison D.M., Edgemond W.S., Campbell W.B. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys. Acta. 1257:1995;249-256.
22. Sugiura T., Kondo S., Sukagawa A., Tonegawa T., Nakane S., Yamashita A., Ishima Y., Waku K. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Eur. J. Biochem. 240:1996;53-62.
23. Schmid H.H.O., Schmid P.C., Natarajan V. The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids. 80:1996;133-142.
24. Kondo S., Sugiura T., Kodaka T., Kudo N., Waku K., Tokumura A. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis. Arch. Biochem. Biophys. 354:1998;303-310.
25. Schmid H.H.O., Schmid P.C., Natarajan V. N-Acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29:1990;1-43.
26. Showalter V.M., Compton D.R., Martin B.R., Abood M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278:1996;989-999.
27. Sheskin T., Hanuš L., Slager J., Vogel Z., Mechoulam R. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 40:1997;659-667.
28. Maurelli S., Bisogno T., De Petrocellis L., Di Luccia A., Marino G., Di Marzo V. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. FEBS Lett. 377:1995;82-86.
29. Bisogno T., Maurelli S., Melck D., De Petrocellis L., Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 272:1997;3315-3323.
30. Priller J., Briley E.M., Mansouri J., Devane W.A., Mackie K., Felder C.C. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol. Pharmacol. 48:1995;288-292.
31. Matsuda S., Kanemitsu N., Nakamura A., Mimura Y., Ueda N., Kurahashi Y., Yamamoto S. Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Exp. Eye Res. 64:1997;707-711.
32. Qin C., Lin S., Lang W., Goutopoulos A., Pavlopoulos S., Mauri F., Makriyannis A. Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography. Anal. Biochem. 261:1998;8-15.
33. Goparaju S.K., Ueda N., Taniguchi K., Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 57:1999;417-423.
34. Deutsch D.G., Omeir R., Arreaza G., Salehani D., Prestwich G.D., Huang Z., Howlett A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. 53:1997;255-260.